News & Updates
Filter by Specialty:
Supplement cocktail boosts COVID-19 treatment arsenal
Daily supplementation with melatonin, zinc, and multivitamins cuts the duration of COVID-19 or COVID-19-like symptoms, thus supplementing the COVID-19 treatment armamentarium, a study has shown.
Supplement cocktail boosts COVID-19 treatment arsenal
29 Apr 2024
New long-term data confirm safety, efficacy of atogepant for migraine prevention
Daily use of the oral calcitonin gene-related peptide (CGRP) receptor antagonist atogepant to prevent migraine is associated with a favourable safety profile and sustained improvements in efficacy outcomes, according to the 52-week data from an ongoing, open-label, 156-week safety extension study.
New long-term data confirm safety, efficacy of atogepant for migraine prevention
27 Apr 2024
Stand Against Prediabetes campaign aiming for early detection, better management
The ‘Stand Against Prediabetes; Don’t Sugarcoat It’ (SAPd) program was recently launched in Putrajaya.
Stand Against Prediabetes campaign aiming for early detection, better management
26 Apr 2024
Ecopipam cuts Tourette tics
Children and adolescents with Tourette syndrome (TS) may benefit from ecopipam, a first-in-class selective dopamine-1 (D1) receptor antagonist, as it reduced the number of tics and level of daily interference in a post hoc analysis of the phase IIb D1AMOND trial.
